📌 Key Takeaways
- Topic: Custom Silica: Tailoring Particle Size, Surface Treatment and Purity to Your Application
- Keywords: hydrophilic fumed silica
- Published: 2026-11-20 06:03:54
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Silica Supplier Europe: Major Producers, Regulations and Sourcing Options
- Silicon Dioxide in Food: Why It Is Added and Whether It Is Safe
- Calcium Carbonate Filler vs Silica: Performance, Cost and Applications Compared
- On The Bright Side
- Silica Oil Absorption: What It Means, Typical Values and How It Affects Formulations
- 57. Narayan R., Nayak U.Y., Raichur A.M., Garg S. Mesoporous silica nanoparticles: A comprehensive review on synthesis and recent advances. Pharmaceutics. 2018;10:118. doi: 10.3390/pharmaceutics10030118. [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Silica Particle Size Guide: How D50, Mesh and Microns Affect Performance
What Is the Dielectric Constant of Silica? Values and Importance in Electronics
What is silica (SiO₂)?
calcium carbonate filler Nanocarriers can be divided into two principal groups: organic and inorganic types. The organic group contains lipid nanocarriers, liposomes, polymeric nanoparticles, dendrimers, etc. In the case of the carriers in this group, the limited volume of delivered active pharmaceutical ingredient (API) is a clear disadvantage, along with decreased stability, and good sensitivity to temperature, pH, and enzymes in a physiological environment. The inorganic group contains metal oxide-, carbon-, silicon-, silica-, and quantum dot-based nanocarriers. Their benefits are greater stability and well-tunable physicochemical properties, but their accumulation in the body may be a key question of their applicability. Silica nanoparticles (SNP) are silicon dioxide (SiO 2 ) nanoparticles in an amorphous state and have excellent potential in the pharmaceutical industry and drug development due to their special properties. According to pore size, the most common, most well-liked, and most effective type of silica nanocarriers are the mesoporous silica nanoparticles (MSNs) [ 1 ].
What is the difference between fumed silica and precipitated silica?
hydrophobic fumed silica Mesoporous silica nanoparticles (MSNs) are a flexible platform for the improvement of water solubility and bioavailability of poorly water-soluble drugs through the stabilization of the API in the amorphous state. Two outstanding mechanisms facilitate such stabilization: physical entrapment within nanoscale pores with a diameter less than the size of the critical nucleus. In this case, the ordered molecular packing necessary to develop crystals cannot advance. Moreover, the unique interactions between the functional groups of APIs and the surface silanol groups of MSNs may immobilize drug molecules at or close to pore walls [ 44, 45 ]. Bavnhøj et al. used celecoxib to demonstrate that when loading is conducted under the pore-filling ability (PFC) of the silica matrix, the drug will be physically stable and amorphous for at least 18 months of dry storage. PFC-loaded along with near-PFC-loaded samples recrystallized, especially upon exposure to moisture, demonstrating the razor-thin margin between the level of loading and stability [ 46 ]. Although advantages are present, long-term stability is undermined by stress recrystallization. For example, α-mangostin began to recrystallize after 7-14 days at 25 °C and 95% relative humidity in MSNs with slightly broader pore size than the molecular size of the API, indicating that pore size must be finely tuned for productive confinement [ 47 ]. Similarly, simvastatin had the longest amorphous lifespan when loaded into pores of 4.5 nm. Still, it exhibited rapid recrystallization in materials with bigger pore size, underlining the critical importance of pore size for the preservation of amorphous stability [ 45, 47 ].
What drives silica raw material prices?
toothpaste grade silica 24. Zhang Y., Wang J., Bai X., Jiang T., Zhang Q., Wang S. Mesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugs. Mol. Pharm. 2012;9:505-513. doi: 10.1021/mp200287c. [ DOI ] [ PubMed ] [ Google Scholar ]
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.